iPSC reprogramming mRNA is a cutting-edge technology used to generate induced pluripotent stem cells (iPSCs) from somatic cells. By delivering reprogramming factors via mRNA, this method offers high efficiency, minimal genomic integration risks, and reduced immunogenicity. It is widely applied in regenerative medicine, disease modeling, and drug discovery. iPSC reprogramming mRNA enables researchers to create patient-specific stem cells, paving the way for personalized therapies and breakthroughs in treating conditions like Parkinson’s, heart disease, and genetic disorders.